A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation. [PDF]
Contracept X, 2023 Halpern V +6 more
europepmc +1 more source
Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis [PDF]
, 1989 I H Russo +3 more
openalex +1 more source
The effects of oral medroxyprogesterone acetate combined with conjugated equine estrogens on inflammation in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Front Endocrinol (Lausanne)Qiu J +5 more
europepmc +1 more source
Depot-medroxyprogesterone acetate: Lipid profile changes and associated cardiovascular risks among acceptors in Sagamu, South West Nigeria. [PDF]
J Public Health Afr, 2023 Odelola O, Akadri A.
europepmc +1 more source
Effect of depot medroxyprogesterone acetate on human β-defensin production and structural integrity of the human vaginal epithelium [PDF]
, 2013 Katherine G. Michel +3 more
openalex +1 more source
Cervical Secretions from Women After Depot Medroxyprogesterone Acetate (Depo-Provera) Administration Promote HIV Infectivity Ex Vivo. [PDF]
VirusesTasker C, Roche NE, Lo Y, Chang TL.
europepmc +1 more source
Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections. [PDF]
Curr HIV/AIDS Rep, 2023 Dabee S +11 more
europepmc +1 more source
A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial) [PDF]
Kensuke Sakai +7 more
openalex +1 more source